Your browser doesn't support javascript.
loading
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.
Guja, Cristian; Kis, János Tibor; Haluzík, Martin; Bonnemaire, Mireille; Bigot, Gregory; Tournay, Mathilde; Freemantle, Nick; Seufert, Jochen.
Affiliation
  • Guja C; Department of Diabetes, Nutrition and Metabolic Disease, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Kis JT; Department of Internal Medicine Centrum, Szent János Hospital, Budapest, Hungary.
  • Haluzík M; Institute for Clinical and Experimental Medicine and Charles University, Prague, Czech Republic.
  • Bonnemaire M; General Medicines, Sanofi, Paris, France.
  • Bigot G; IVIDATA, Paris, France.
  • Tournay M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
  • Freemantle N; Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Seufert J; Division of Endocrinology and Diabetology, Department of Internal Medicine II, Medical Centre - Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diabetes Obes Metab ; 25(6): 1723-1730, 2023 06.
Article in En | MEDLINE | ID: mdl-36810874
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: Romania
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: Romania